# XXYLT1

## Overview
XXYLT1 is a gene that encodes the enzyme xyloside xylosyltransferase 1, a type II membrane protein involved in the glycosylation of epidermal growth factor (EGF) repeats. This enzyme is a member of the glycosyltransferase family 8 (GT8) and is characterized by a GT-A fold and a conserved DXD motif, which are essential for its enzymatic activity (Yu2015Notchmodifying; Yan2020The). Located in the endoplasmic reticulum, xyloside xylosyltransferase 1 plays a crucial role in the post-translational modification of proteins, particularly in the Notch signaling pathway, by adding a second xylose residue to O-glucosylated EGF repeats (Sethi2012Molecular). This modification is vital for proper Notch receptor function, impacting cellular processes such as differentiation, proliferation, and apoptosis (Yu2015Notchmodifying). Dysregulation of XXYLT1 expression has been associated with various diseases, including cancer and congenital disorders of glycosylation, highlighting its clinical significance (Pandey2018Sensitized; Hansen2014A).

## Structure
The XXYLT1 protein is a type II membrane protein involved in the glycosylation of epidermal growth factor (EGF) repeats. It is characterized by a GT-A fold, a common structural motif in glycosyltransferases, which includes a conserved Asp-X-Asp (DXD) motif that coordinates a Mn2+ ion essential for its enzymatic activity (Yu2015Notchmodifying; Yan2020The). The primary structure of XXYLT1 includes approximately 300 amino acids, forming a catalytic domain that protrudes into the lumen of the endoplasmic reticulum (Yu2015Notchmodifying).

The tertiary structure of XXYLT1 reveals a dimeric form in the crystal lattice, facilitating its function in modifying Notch receptors. The enzyme's active site is oriented to interact with luminally oriented EGF repeats, and the binding of the acceptor substrate induces significant conformational changes in the EGF repeat, although the enzyme itself remains largely unchanged upon binding (Yu2015Notchmodifying).

XXYLT1 is a retaining glycosyltransferase, meaning it retains the stereochemistry of the α-linked xylose after transfer. The enzyme's mechanism involves an SNi-like retaining mechanism, with the O3 hydroxyl of the acceptor xylose acting as the nucleophile (Yu2015Notchmodifying). The protein is located in the endoplasmic reticulum, as confirmed by immunofluorescence studies (Sethi2012Molecular).

## Function
XXYLT1 is a xylosyltransferase enzyme that plays a critical role in the post-translational modification of proteins, specifically in the glycosylation of epidermal growth factor (EGF) repeats on the Notch receptor. This enzyme catalyzes the addition of a second xylose residue to O-glucosylated EGF repeats, forming a trisaccharide structure (Xyl-Xyl-Glc-O) that is essential for proper Notch signaling (Sethi2012Molecular). Notch signaling is crucial for various cellular processes, including cell differentiation, proliferation, and apoptosis, and is vital for the development of all metazoans (Yu2015Notchmodifying).

XXYLT1 is a type II membrane protein located in the endoplasmic reticulum, with its catalytic domain protruding into the lumen. It belongs to glycosyltransferase family 8 (GT8) and retains the stereochemistry of the α-linked xylose after transfer (Yu2015Notchmodifying). The enzyme's activity is crucial for maintaining the balance of Notch activation, as dysregulation can lead to diseases such as cancer and developmental disorders (Yu2015Notchmodifying). The proper functioning of XXYLT1 ensures the correct folding and trafficking of Notch receptors, impacting cell signaling pathways and organismal development (Urata2020Xylosyl).

## Clinical Significance
The human gene XXYLT1 is implicated in various diseases, particularly due to its role in glycosylation processes. Alterations in the expression of XXYLT1 have been associated with cancer. The gene is frequently amplified in several cancer types, which are often linked to decreased Notch signaling, suggesting that XXYLT1 may play an inhibitory role in this pathway (Pandey2018Sensitized). This amplification could contribute to the pathogenesis of cancers by affecting the regulation of Notch signaling, a pathway crucial for cell differentiation and proliferation.

In addition to cancer, the XXYLT1 gene is related to congenital disorders of glycosylation (CDGs), a group of metabolic disorders caused by defects in glycosylation. These disorders can lead to a wide range of symptoms, including developmental delays and metabolic abnormalities (Hansen2014A). While specific mutations in XXYLT1 have not been directly linked to CDGs, the gene's role in glycosylation suggests it could be involved in such conditions.

Overall, the clinical significance of XXYLT1 is primarily linked to its involvement in glycosylation and its potential impact on Notch signaling, which may contribute to the development of cancer and other glycosylation-related disorders.

## Interactions
XXYLT1, a xylosyltransferase enzyme, is involved in the modification of Notch receptors through the addition of xylose to the epidermal growth factor (EGF) repeats. This enzyme interacts with the EGF repeats of Notch receptors, facilitating a significant conformational change upon binding. This interaction is characterized by specific hydrogen bonds and stacking interactions, which are crucial for the enzyme's function (Yu2015Notchmodifying).

The enzyme forms a dimer, which is thought to enhance its interaction with the endoplasmic reticulum (ER) membrane and the EGF repeats of Notch, suggesting a structural basis for its substrate specificity and function (Yu2015Notchmodifying). The presence of disulfide bonds in the EGF repeat is also essential for the interaction, contributing to the rigid binding surface necessary for the enzyme's activity (Yu2015Notchmodifying).

XXYLT1's interaction with its substrates is further supported by its structural analysis, which reveals a GT-A fold and a glycosyltransferase signature DXD motif. These structural features facilitate the enzyme's role in the Notch signaling pathway, which is significant in various cellular processes and diseases, including cancer (Yu2015Notchmodifying).


## References


[1. (Pandey2018Sensitized) Ashutosh Pandey, David Li-Kroeger, Maya K Sethi, Tom V Lee, Falk FR Buettner, Hans Bakker, and Hamed Jafar-Nejad. Sensitized genetic backgrounds reveal differential roles for egf repeat xylosyltransferases in drosophila notch signaling. Glycobiology, 28(11):849–859, September 2018. URL: http://dx.doi.org/10.1093/glycob/cwy080, doi:10.1093/glycob/cwy080. This article has 13 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/glycob/cwy080)

[2. (Sethi2012Molecular) Maya K. Sethi, Falk F.R. Buettner, Angel Ashikov, Vadim B. Krylov, Hideyuki Takeuchi, Nikolay E. Nifantiev, Robert S. Haltiwanger, Rita Gerardy-Schahn, and Hans Bakker. Molecular cloning of a xylosyltransferase that transfers the second xylose to o-glucosylated epidermal growth factor repeats of notch. Journal of Biological Chemistry, 287(4):2739–2748, January 2012. URL: http://dx.doi.org/10.1074/jbc.m111.302406, doi:10.1074/jbc.m111.302406. This article has 74 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m111.302406)

[3. (Yan2020The) Lijuan Yan and Yongjun Liu. The retaining mechanism of xylose transfer catalyzed by xyloside α-1,3-xylosyltransferase (xxylt1): a quantum mechanics/molecular mechanics study. Journal of Chemical Information and Modeling, 60(3):1585–1594, February 2020. URL: http://dx.doi.org/10.1021/acs.jcim.9b00976, doi:10.1021/acs.jcim.9b00976. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1021/acs.jcim.9b00976)

[4. (Yu2015Notchmodifying) Hongjun Yu, Megumi Takeuchi, Jamie LeBarron, Joshua Kantharia, Erwin London, Hans Bakker, Robert S Haltiwanger, Huilin Li, and Hideyuki Takeuchi. Notch-modifying xylosyltransferase structures support an sni-like retaining mechanism. Nature Chemical Biology, 11(11):847–854, September 2015. URL: http://dx.doi.org/10.1038/nchembio.1927, doi:10.1038/nchembio.1927. This article has 63 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/nchembio.1927)

[5. (Urata2020Xylosyl) Yusuke Urata, Wataru Saiki, Yohei Tsukamoto, Hiroaki Sago, Hideharu Hibi, Tetsuya Okajima, and Hideyuki Takeuchi. Xylosyl extension of o-glucose glycans on the extracellular domain of notch1 and notch2 regulates notch cell surface trafficking. Cells, 9(5):1220, May 2020. URL: http://dx.doi.org/10.3390/cells9051220, doi:10.3390/cells9051220. This article has 22 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/cells9051220)

[6. (Hansen2014A) Lars Hansen, Allan Lind-Thomsen, Hiren J Joshi, Nis Borbye Pedersen, Christian Theil Have, Yun Kong, Shengjun Wang, Thomas Sparso, Niels Grarup, Malene Bech Vester-Christensen, Katrine Schjoldager, Hudson H Freeze, Torben Hansen, Oluf Pedersen, Bernard Henrissat, Ulla Mandel, Henrik Clausen, Hans H Wandall, and Eric P Bennett. A glycogene mutation map for discovery of diseases of glycosylation. Glycobiology, 25(2):211–224, September 2014. URL: http://dx.doi.org/10.1093/glycob/cwu104, doi:10.1093/glycob/cwu104. This article has 49 citations and is from a peer-reviewed journal.](https://doi.org/10.1093/glycob/cwu104)